A comparative study of the efficacy of coenzyme Q10 and amitriptyline in the prophylactic treatment of migraine headaches in children; An open-label randomized controlled trial

Esfahan University of Medical Sciences0 个研究点目标入组 72 人开始时间: 待定最近更新: 2020年1月13日

适应症

试验速览

暂无简介。

•Children with migraine with or without aura referred to a clinic of neurology and disease is diagnosed definitively on the basis of IHS.
•Migraine attacks occur at least twice a week or four times a month, forcing them to consume or disrupt their daily activities.
•Children 5 to 15 year old

•Patients' unwillingness to cooperate during the study.
•Severe and uncontrolled side effects of Q10 or Amitriptyline
•If a diagnosis other than migraine is made during the study, based on possible laboratory or imaging findings
•Complicated migraine or epilepsy
•Lack of ability to record data on the frequency, duration, and severity of headaches
•Taking prophylaxis other than Q10 and amitriptyline
•Children with migraines with severe psychiatric problems such as ADHD and depression
•Using painkillers more than 4 times a week to control migraine attacks (severe forms of migraines)
•A history of allergy to similar drugs

发起方